NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Solange Peters
Université de Lausanne - Lausanne / Switzerland
Others
AD Scientific Index ID: 4690648
Universität Lausanne
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Solange Peters's MOST POPULAR ARTICLES
1-)
Comprehensive molecular profiling of lung adenocarcinoma Cancer Genome Atlas Research Network Nature 511 (7511), 543, 2014 3972*2014
2-)
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upD Planchard, ST Popat, K Kerr, S Novello, EF Smit, C Faivre-Finn, TS Mok, ...Annals of Oncology 29, iv192-iv237, 2018
3-)
First-line nivolumab in stage IV or recurrent non–small-cell lung cancerDP Carbone, M Reck, L Paz-Ares, B Creelan, L Horn, M Steins, E Felip, ...New England Journal of Medicine 376 (25), 2415-2426, 2017
4-)
Nivolumab plus ipilimumab in advanced non–small-cell lung cancerMD Hellmann, L Paz-Ares, R Bernabe Caro, B Zurawski, SW Kim, ...New England Journal of Medicine 381 (21), 2020-2031, 201925312019
5-)
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung CancerS Peters, DR Camidge, AT Shaw, S Gadgeel, JS Ahn, DW Kim, SHI Ou, ...New England Journal of Medicine 377 (9), 829-838, 201725022017
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept